文献速递肥胖与代谢综合征糖尿病

母亲孕前体重指数、孕早期代谢物谱与出生体重

Maternal Body Mass Index, Early-Pregnancy Metabolite Profile, and Birthweight.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

基于Generation R前瞻性队列中682名荷兰孕妇,研究孕前BMI与孕早期代谢物改变的关系,并识别与出生体重相关的代谢物谱。孕前BMI较高与72种代谢物改变及6种代谢物比值相关;所选代谢物谱使出生体重调整R²从6.1%提升至12.9%。

要点

  • 孕前BMI较高与孕早期氨基酸、非酯化脂肪酸、磷脂和肉碱的广泛改变相关。
  • 基于15种代谢物和4种比值的代谢物谱可改善出生体重预测。
  • 代谢物谱对出生体重预测的改善优于血糖和血脂指标。

核心结论

  • 孕前BMI较高与孕早期氨基酸、非酯化脂肪酸、磷脂和肉碱改变相关。
  • 所识别的代谢物谱在孕前BMI较高的女性中改善了出生体重预测。

研究设计与样本

  • Generation R前瞻性队列研究子组,纳入682名荷兰孕妇。
  • 孕前BMI通过问卷或记录获取,孕早期平均12.8周测量非空腹血清代谢物。
  • 出生体重来自医疗记录。

主要发现

  • 孕前BMI较高与72种氨基酸、非酯化脂肪酸、磷脂和肉碱浓度改变及6种代谢物比值相关(P值<0.05)。
  • 惩罚回归模型选出包含15种代谢物和4种代谢物比值的代谢物谱。
  • 出生体重调整R²:仅孕前BMI为6.1%,加入血糖和血脂后为6.2%,加入代谢物谱后为12.9%。

关键数值与推荐

  • 孕前BMI较高与72种代谢物改变和6种代谢物比值相关(P值<0.05)。
  • 代谢物谱包含15种代谢物和4种代谢物比值。
  • 出生体重调整R²:仅孕前BMI 6.1%,加血糖血脂6.2%,加代谢物谱12.9%。

临床怎么用

  • 孕早期代谢物谱可能辅助识别孕前BMI较高女性的出生体重风险。
  • 代谢物谱对出生体重的预测改善优于单独使用血糖和血脂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Maternal prepregnancy body mass index (BMI) has a strong influence on gestational metabolism, but detailed metabolic alterations are unknown. OBJECTIVE: First, to examine the associations of maternal prepregnancy BMI with maternal early-pregnancy metabolite alterations. Second, to identify an early-pregnancy metabolite profile associated with birthweight in women with a higher prepregnancy BMI that improved prediction of birthweight compared to glucose and lipid concentrations. DESIGN, SETTING, AND PARTICIPANTS: Prepregnancy BMI was obtained in a subgroup of 682 Dutch pregnant women from the Generation R prospective cohort study. MAIN OUTCOME MEASURES: Maternal nonfasting targeted amino acids, nonesterified fatty acid, phospholipid, and carnitine concentrations measured in blood serum at mean gestational age of 12.8 weeks. Birthweight was obtained from medical records. RESULTS: A higher prepregnancy BMI was associated with 72 altered amino acids, nonesterified fatty acid, phospholipid and carnitine concentrations, and 6 metabolite ratios reflecting Krebs cycle, inflammatory, oxidative stress, and lipid metabolic processes (P-values < 0.05). Using penalized regression models, a metabolite profile was selected including 15 metabolites and 4 metabolite ratios based on its association with birthweight in addition to prepregnancy BMI. The adjusted R2 of birthweight was 6.1% for prepregnancy BMI alone, 6.2% after addition of glucose and lipid concentrations, and 12.9% after addition of the metabolite profile. CONCLUSIONS: A higher maternal prepregnancy BMI was associated with altered maternal early-pregnancy amino acids, nonesterified fatty acids, phospholipids, and carnitines. Using these metabolites, we identified a maternal metabolite profile that improved prediction of birthweight in women with a higher prepregnancy BMI compared to glucose and lipid concentrations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wahab RJ, Jaddoe VWV, Voerman E, et al. Maternal Body Mass Index, Early-Pregnancy Metabolite Profile, and Birthweight. J Clin Endocrinol Metab. 2022. PMID: 34390344. doi:10.1210/clinem/dgab596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。